Skip to main content

Table 6 Diagnostic Capabilities of MCB tests by Gender and Age

From: The feasibility and diagnostic accuracy by multiple cardiac biomarkers in emergency chest pain patients: a clinical analysis to compare 290 suspected acute coronary syndrome cases stratified by age and gender in Taiwan

 

≥65 years old (N = 146)

<65 years old (N = 144)

Male (N = 75)

Female (N = 71)

Male (N = 106)

Female (N = 38)

Sensitivity

73.7 % (51.2–88.2)

87.5 % (64–96.5)

52.9 % (36.7–68.5)

50.0 % (15.0–85.0)

Specificity

46.4 % (34.0–59.3)

41.8 % (29.7–55.0)

81.9 % (71.5–89.1)

91.2 % (77.0–97.0)

PPV

31.8 % (20.0–46.6)

30.4 % (19.1–44.8)

58.1 % (40.8–73.6)

40.0 % (11.8–76.9)

NPV

83.9 % (71.1–89.2)

92 % (75.0–97.8)

78.7 % (68.1–86.4)

93.9 % (80.4–98.3)

LR+

1.37 (0.96–1.98)

1.50 (1.12–2.01)

2.93 (1.63–5.26)

5.67 (1.32–24.37)

LR−

0.57 (0.25–1.26)

0.29 (0.08–1.13)

0.57 (0.39–0.83)

0.55 (0.20–1.47)

  1. PS: PPV, NPV, LR+ and LR− mean positive and negative predictive values, positive and negative likelihood ratios, respectively